Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Thermo Fisher Scientific launches new MSIA Strepdavidin EVO microcolumns

Thermo Fisher Scientific launches new MSIA Strepdavidin EVO microcolumns

26th February 2016

Thermo Fisher Scientific has announced the launch of its new MSIA Strepdavidin EVO microcolumns, a next-generation large molecule affinity purification solution.

This fully automated solution is designed to aid the analysis of large biomolecules such as proteins and antibodies with improved accuracy, consistency and simplicity, even at high throughputs.

Incorporating novel mass spectrometric immunoassay (MSIA) affinity purification technology, the system is designed to be used in combination with Tecan's Freedom EVO series of robotic platforms.

The microcolumns enable fast and accurate isolation of target analytes from complex biological matrices, thus improving biotherapeutic, disease biomarker and sports anti-doping bioanalysis.

Preeti Saini, product manager for MSIA liquid handling consumables at Thermo Fisher Scientific, said: "The MSIA Streptavidin EVO microcolumn is an ideal solution for biologics and biosimilars discovery and development."

Earlier this month, the company announced the acquisition of INEL, a provider of real-time X-ray diffraction systems based in France. This takeover will further expand its offering of analytical instruments.ADNFCR-8000103-ID-801813536-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.